Biden Shouts Out ‘Cancer Moonshot’ In State Of The Union

The annual address also included discussion of legislation passed to improve the US supply of semiconductor chips, as well as new research body ARPA-H.

Biden address to Congress 28 April 2021.  Photo by Doug Mills - Pool/Getty Images
• Source: Doug Mills - Pool/Getty Images

US President Joe Biden remains committed to a Cancer Moonshot initiative to “end cancer as we know it,” the chief executive said in his annual State of the Union address Tuesday night.

“Our goal is to cut the cancer death rates at least by 50 percent in the next 25 years,” he said. “Turn more cancers from death sentences to treatable diseases....

More from Leadership

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By 

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.